Genosity is a biotechnology company that provides software and laboratory services for clinical and research applications of genomics, so its partners can fully realize the value of precision medicine while improving patient care
How EPAM & Genosity Implemented a Next-Gen Security Solution
Genosity offers a software-as-a-service (SaaS) product, Integrated Genomics Toolkit (IGT), which is a comprehensive solution enabling genomic laboratories to generate and leverage next-generation sequencing (NGS) data for clinical genetic testing as well as meaningful analytics for research collaborations.
With increasing regulations around data management and the possibility of cyber threats, healthcare institutions constantly face new challenges around the secure retention of large-scale data with Protected Health Information (PHI). As a cloud-based SaaS provider to NGS laboratories, Genosity’s products need to comply with a myriad of data security regulations including the Health Insurance Portability and Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR). IGT is an end-to-end platform deployed in AWS under stringent security policies that are constantly monitored by EPAM and Genosity.
Project highlights include:
- Fast turnaround for security assessment
- Ability to perform assessment and provide applicable and actionable recommendations at the late stage of development
- EPAM-developed security best practices
EPAM provided Genosity an infrastructure meeting HIPAA requirements with security findings remediations. This implementation ensured that Genosity could maintain the regulatory standards required for the security of PHI handled by Genosity and its clients.